en

PRODUCT DETAIL

Enjaymo 50 mg/ml infúzny roztok

Code 2459E
MA number EU/1/22/1687/001
Product Form: sol inf 1x22 ml/1100 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU Orphan
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA55 Sutimlimab
Shelf life: 24
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 15.11.2022
Validity: 15.11.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 02.12.2022
eu-flag.png sk-flag.png